Exagen Diagnostics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Exagen Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012885
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exagen Diagnostics Inc (Exagen) is a medical device company that offers diagnostic tools. The company provides clinical tools for diagnosis, monitoring and prognosis of autoimmune connective tissue disease. Its products are used for therapeutic drug monitoring of hydroxychloroquine in whole blood and methotrexate polyglutamates, risk assessment testing, anti-TNF monitoring to individualize therapy and optimize dosing, and others. Exagen offers avise ctd, avise sle prognostic, avise infliximab and avise adalimumab, avise hcq, and avise mtx. The company serves physicians and patients. It operates in Vista and Albuquerque, the US. Exagen is headquartered in Vista, California, the US.

Exagen Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Exagen Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Exagen Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Exagen Diagnostics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Exagen Diagnostics Raises USD1.3 Million in Venture Financing 10
Exagen Diagnostics Raises USD1.5 Million in Venture Financing 11
Exagen Diagnostics Raises USD1 Million in Venture Financing 12
Exagen Diagnostics Raises USD1 Million in Venture Financing 13
Exagen Diagnostics Raises USD1 Million in Venture Financing 14
Exagen Diagnostics Raises USD1 Million in Venture Financing 15
Exagen Diagnostics Raises USD1 Million in Venture Financing 16
Exagen Diagnostics Raises USD1 Million in venture financing 17
Exagen Diagnostics Raises USD2 Million in Venture Financing 18
Exagen Diagnostics Raises USD16.81 Million in Venture Financing 19
Exagen Diagnostics Raises USD3 Million in Venture Financing 20
Exagen Diagnostics Raises USD2 Million in Venture Financing 21
Exagen Diagnostics Raises USD4 Million in Venture Financing 22
Exagen Diagnostics Raises US$5 Million In Venture Financing 23
Exagen Diagnostics Raises US$0.12 Million In Venture Financing 24
Exagen Raises US$5.3 Million In Venture Financing 25
Exagen Diagnostics Secures US$12 Million In Series D Venture Financing 26
Exagen Diagnostics Secures Additional US$3.4 Million In Financing Round 27
Exagen Diagnostics Inc – Key Competitors 28
Exagen Diagnostics Inc – Key Employees 29
Exagen Diagnostics Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Product News 31
Oct 31, 2017: Exagen Diagnostics Featured in Five Scientific Posters at 2017 ACR/ARHP Annual Meeting in San Diego 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Exagen Diagnostics Inc, Medical Equipment, Key Facts 2
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Exagen Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Exagen Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Exagen Diagnostics Raises USD1.3 Million in Venture Financing 10
Exagen Diagnostics Raises USD1.5 Million in Venture Financing 11
Exagen Diagnostics Raises USD1 Million in Venture Financing 12
Exagen Diagnostics Raises USD1 Million in Venture Financing 13
Exagen Diagnostics Raises USD1 Million in Venture Financing 14
Exagen Diagnostics Raises USD1 Million in Venture Financing 15
Exagen Diagnostics Raises USD1 Million in Venture Financing 16
Exagen Diagnostics Raises USD1 Million in venture financing 17
Exagen Diagnostics Raises USD2 Million in Venture Financing 18
Exagen Diagnostics Raises USD16.81 Million in Venture Financing 19
Exagen Diagnostics Raises USD3 Million in Venture Financing 20
Exagen Diagnostics Raises USD2 Million in Venture Financing 21
Exagen Diagnostics Raises USD4 Million in Venture Financing 22
Exagen Diagnostics Raises US$5 Million In Venture Financing 23
Exagen Diagnostics Raises US$0.12 Million In Venture Financing 24
Exagen Raises US$5.3 Million In Venture Financing 25
Exagen Diagnostics Secures US$12 Million In Series D Venture Financing 26
Exagen Diagnostics Secures Additional US$3.4 Million In Financing Round 27
Exagen Diagnostics Inc, Key Competitors 28
Exagen Diagnostics Inc, Key Employees 29
Exagen Diagnostics Inc, Other Locations 30

★海外企業調査レポート[Exagen Diagnostics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amunix Operating Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Amunix Operating Inc (Amunix) is a biotechnology company that discovers and develops long-acting protein-based therapeutics. The company develops protein and peptide therapeutics. It uses its proprietary technology platform XTEN, a proprietary recombinant polypeptide that consists of natural …
  • Schreiber Foods, Inc.:企業の戦略・SWOT・財務情報
    Schreiber Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Schreiber Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SGL Carbon SE:企業の戦略・SWOT・財務情報
    SGL Carbon SE - Strategy, SWOT and Corporate Finance Report Summary SGL Carbon SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Visa Inc.:戦略・SWOT・企業財務分析
    Visa Inc. - Strategy, SWOT and Corporate Finance Report Summary Visa Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • TG Therapeutics Inc (TGTX):企業の財務・戦略的SWOT分析
    TG Therapeutics Inc (TGTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Event Hospitality & Entertainment Ltd:企業の戦略・SWOT・財務情報
    Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Raysearch Laboratories AB (RAY B):企業の財務・戦略的SWOT分析
    Summary RaySearch Laboratories AB (RaySearch) is a medical technology company that develops software solutions for radiation therapy of cancer. The company provides software products such as rayplan, raystation and raycare. Its services include installation, support, training and training schedule. …
  • GEA Group Aktiengesellschaft:企業の戦略・SWOT・財務分析
    GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Veloxis Pharmaceuticals AS (VELO)-製薬・医療分野:企業M&A・提携分析
    Summary Veloxis Pharmaceuticals A/S (Veloxis) is a specialty pharmaceutical company, which develops therapies for kidney transplantation based on its proprietary MeltDose platform. MeltDose is a drug delivery technology, used to enhance oral bioavailability and control release of a drug. The company …
  • Euro India Fresh Foods Ltd (EIFFL):企業の財務・戦略的SWOT分析
    Euro India Fresh Foods Ltd (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Sohar Aluminium LLC:企業の戦略・SWOT・財務情報
    Sohar Aluminium LLC - Strategy, SWOT and Corporate Finance Report Summary Sohar Aluminium LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Applied Genetic Technologies Corp (AGTC):医療機器:M&Aディール及び事業提携情報
    Summary Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pi …
  • Sinohydro Corporation Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Sinohydro Corporation Co., Ltd (Sinohydro), a subsidiary of China Hydropower Construction Group International Engineering Co., Ltd., is an engineering and construction company. Its portfolio of services includes general construction, engineering, procurement and construction (EPC), and inves …
  • Chunghwa Post Co., Ltd.:企業の戦略・SWOT・財務分析
    Chunghwa Post Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chunghwa Post Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bank of Queensland Ltd (BOQ):企業の財務・戦略的SWOT分析
    Bank of Queensland Ltd (BOQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Bank of Okinawa, Ltd. (8397):企業の財務・戦略的SWOT分析
    The Bank of Okinawa, Ltd. (8397) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Qurient Co Ltd (115180)-製薬・医療分野:企業M&A・提携分析
    Summary Qurient Co Ltd (Qurient) is a biotechnology company that focuses on the development of new drugs for unmet medical needs. The company’s portfolio of pipeline products includes Q301, Q203, Q701, 5LO INH and CDK7 INH among others. The company is developing products for the treatment of atopic …
  • METRO Retail Stores Group Inc (MRSGI):企業の財務・戦略的SWOT分析
    METRO Retail Stores Group Inc (MRSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Banco Bilbao Vizcaya Argentaria SA:戦略・SWOT・企業財務分析
    Banco Bilbao Vizcaya Argentaria SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bilbao Vizcaya Argentaria SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • FirstEnergy Corp (FE)-エネルギー分野:企業M&A・提携分析
    Summary FirstEnergy Corp. (FirstEnergy) is a diversified energy company, which generates, transmits, distributes and sells electricity. The company’s regulated distribution companies form one of the nation's largest investor-owned electric systems. Its major electricity generating assets include coa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆